This site is intended for healthcare professionals only
LoginRegister
Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag InternationalJohnson and Johnson Gets CDSCO Panel Nod To study Guselkumab in Psoriatic Arthritis
Aurobindo Pharma Q3 Net Profit Rises 8% to Rs 910 CrAurobindo Pharma to Begin European Supply from China Facility in April
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationBiological E Gets CDSCO Panel Nod To Study Inactivated Poliomyelitis Vaccine
DCC Approves RealTime Digital Portal to Track NDPS Regulated Pharma ProductsHealth Ministry Invites Application For Deputy Director at CDSCO's CDTL Mumbai, Salary Up to Rs 2.09...
NPPA Finally Allows GSK to Discontinue Grisovin FPGSK Pharma's Q3 Profit Jumps 35% on Strong Demand for Augmentin, Respiratory Drugs
Himachal cracks down on pharma units, action taken against four facilitiesSurprise Inspection of Pharma Firms in Baddi Amid Counterfeit Drug Concerns
Modernas Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales SlumpModerna's Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales Slump
West Pharmas 2025 Forecast Misses Estimates as Inventory Reductions ContinueWest Pharma's 2025 Forecast Misses Estimates as Inventory Reductions Continue
CDSCO Panel Approves BE Study for Alkems Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III PlanRetinal examination be done at each visit: CDSCO Panel tells Alkem Lab on Semaglutide Injection...
Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP NormsZydus' Ambernath API Plant Clears USFDA Inspection with Zero Observations
AIMSS Infrastructure Delays Trigger HP High Court WarningCourt Relief: Pharma MD Gets Bail After 22-Month Jail In Tramadol Smuggling Case
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataUS Market Pressure Weighs on Glenmark's Q3 Earnings, Profit Below Estimates
X